?

This announcement replaces the original announcement released on 3 January 2014 at 9.43am (RNS No: 8550W).

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc (the Company).

On 31 December 2013, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company through the annual reinvestment of dividends paid throughout 2013; calculated using an average price of £16.073 per Ordinary Share and $53.170 per ADS:

Non-Executive Director

Ordinary Shares

No. of ADSs

Sir Christopher Gent

4,466.364

Prof Sir Roy Anderson

685.862      

Dr Stephanie Burns

538.531

Stacey Cartwright

125.504

Lynn Elsenhans

78.145

Judy Lewent

        80.720

Sir Deryck Maughan

1,379.853

Dr Daniel Podolsky

968.774

Tom de Swaan

998.268

Jing Ulrich

24.625

Hans Wijers

3.630

Sir Robert Wilson

1,032.435

The Company and the Non-Executive Directors were informed of these allocations on 2 January 2014.

This notification relates to transactions notified in accordance withDisclosure and Transparency Rule 3.1.4R(1)(a).

Sonja Arseni?

Corporate Secretariat

15 January 2014


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSDMGMMVKKGDZM
distributed by